# Sanofi > Alpha governed public record. Unknown, unavailable, and unpublished values are never inferred as zero. ## Record | Field | Value | | --- | --- | | Representation | alpha-profile-markdown-v4 | | Protocol | Alpha Governance Facts Protocol 0.1 | | Schema | alpha.governance.entity.public.v1 | | Record version | public-1:ro-d751713988987e9331980363e24189ce | | Governance record representation | alpha-governance-record-v2 | | Canonical entity | alpha:company:6f05ca0c-a52c-469e-bd04-7efad28236e7 | | Entity type | Company | | Canonical URL | https://registry.alpha.ac/companies/sanofi | | Publication | PUBLISHED | | Verification | source_reported | | Verification schema | alpha-verification-states-v1 | | Ownership | unclaimed | | Published claims | 38 | | Claims under review | 2 | | Evidence records | 9 | | Conflicts | 0 | | Conflicts in internal review | 0 | | Observed | 2026-10-23T04:48:33.968896+00:00 | | Last reviewed | 2026-10-23T04:48:33.968896+00:00 | ## Identity - Legal name: Sanofi - Display name: Sanofi ## Alpha Governance Record | Field | Value | | --- | --- | | Governance Record schema | alpha-governance-record-v2 | | Ontology | alpha-governance-ontology-v1 | | Record version | public-1:ro-d751713988987e9331980363e24189ce | | As of | 2026-10-23T04:48:33.968896+00:00 | | Completeness | 0.364 | | Record Quality | 0.729 | | Directors | 16 | | Committees | 0 | | Governance events | 0 | | Entity class | public_company | ## Section coverage | Section | State | | --- | --- | | identity | PUBLISHED | | corporate_structure | NOT_REVIEWED | | board | PUBLISHED | | committees | NOT_REVIEWED | | leadership | PUBLISHED | | ownership | NOT_REVIEWED | | financials | NOT_REVIEWED | | capital_structure | PUBLISHED | | compensation | NOT_REVIEWED | | governance | NOT_REVIEWED | | shareholder_governance | NOT_REVIEWED | | audit | NOT_REVIEWED | | legal | NOT_REVIEWED | | risk | NOT_REVIEWED | | cyber | NOT_REVIEWED | | ai_governance | NOT_REVIEWED | | agent_governance | RESTRICTED | | markets_external | PUBLISHED | | events | INSUFFICIENT_EVIDENCE | | relationships | PUBLISHED | | assessments | PUBLISHED | | evidence | PUBLISHED | ## Board - Anne-Françoise Nesmes: Independent director. Status: unknown. Independent: true. Since: NOT_PUBLISHED. claim_id=alpha:claim:company:6f05ca0c-a52c-469e-bd04-7efad28236e7:leadership_role:8 - Antoine Yver: Independent director. Status: unknown. Independent: true. Since: NOT_PUBLISHED. claim_id=alpha:claim:company:6f05ca0c-a52c-469e-bd04-7efad28236e7:leadership_role:9 - Barbara Lavernos: Director. Status: unknown. Independent: NOT_PUBLISHED. Since: NOT_PUBLISHED. claim_id=alpha:claim:company:6f05ca0c-a52c-469e-bd04-7efad28236e7:leadership_role:10 - Belén Garijo: Director. Status: unknown. Independent: NOT_PUBLISHED. Since: NOT_PUBLISHED. claim_id=alpha:claim:company:6f05ca0c-a52c-469e-bd04-7efad28236e7:leadership_role:11 - Carole Ferrand: Independent director. Status: unknown. Independent: true. Since: NOT_PUBLISHED. claim_id=alpha:claim:company:6f05ca0c-a52c-469e-bd04-7efad28236e7:leadership_role:12 - Christel Heydemann: Independent director. Status: unknown. Independent: true. Since: NOT_PUBLISHED. claim_id=alpha:claim:company:6f05ca0c-a52c-469e-bd04-7efad28236e7:leadership_role:13 - Christophe Babule: Director. Status: unknown. Independent: NOT_PUBLISHED. Since: NOT_PUBLISHED. claim_id=alpha:claim:company:6f05ca0c-a52c-469e-bd04-7efad28236e7:leadership_role:14 - Clotilde Delbos: Independent director. Status: unknown. Independent: true. Since: NOT_PUBLISHED. claim_id=alpha:claim:company:6f05ca0c-a52c-469e-bd04-7efad28236e7:leadership_role:15 - Emile Voest: Independent director. Status: unknown. Independent: true. Since: NOT_PUBLISHED. claim_id=alpha:claim:company:6f05ca0c-a52c-469e-bd04-7efad28236e7:leadership_role:16 - Frédéric Oudéa: Chairman of the Board of Directors. Status: unknown. Independent: false. Since: NOT_PUBLISHED. claim_id=alpha:claim:company:6f05ca0c-a52c-469e-bd04-7efad28236e7:leadership_role:7 - Humberto De Sousa: Director representing employees. Status: unknown. Independent: false. Since: NOT_PUBLISHED. claim_id=alpha:claim:company:6f05ca0c-a52c-469e-bd04-7efad28236e7:leadership_role:17 - Jean-Paul Kress: Independent director. Status: unknown. Independent: true. Since: NOT_PUBLISHED. claim_id=alpha:claim:company:6f05ca0c-a52c-469e-bd04-7efad28236e7:leadership_role:18 - John Sundy: Independent director. Status: unknown. Independent: true. Since: NOT_PUBLISHED. claim_id=alpha:claim:company:6f05ca0c-a52c-469e-bd04-7efad28236e7:leadership_role:19 - Lise Kingo: Independent director. Status: unknown. Independent: true. Since: NOT_PUBLISHED. claim_id=alpha:claim:company:6f05ca0c-a52c-469e-bd04-7efad28236e7:leadership_role:20 - Rachel Duan: Independent director. Status: unknown. Independent: true. Since: NOT_PUBLISHED. claim_id=alpha:claim:company:6f05ca0c-a52c-469e-bd04-7efad28236e7:leadership_role:21 - Wolfgang Laux: Director representing employees. Status: unknown. Independent: false. Since: NOT_PUBLISHED. claim_id=alpha:claim:company:6f05ca0c-a52c-469e-bd04-7efad28236e7:leadership_role:22 ## Executive leadership - Belén Garijo: Chief Executive Officer [CEO]. Status: unknown. claim_id=alpha:claim:company:6f05ca0c-a52c-469e-bd04-7efad28236e7:leadership_role:23 - Brendan O'Callaghan: Executive Vice President, Manufacturing & Supply. Status: unknown. claim_id=alpha:claim:company:6f05ca0c-a52c-469e-bd04-7efad28236e7:leadership_role:24 - François Roger: Executive Vice President, Finance. Status: unknown. claim_id=alpha:claim:company:6f05ca0c-a52c-469e-bd04-7efad28236e7:leadership_role:25 - Jamie Haney: Executive Vice President, General Counsel [GC]. Status: unknown. claim_id=alpha:claim:company:6f05ca0c-a52c-469e-bd04-7efad28236e7:leadership_role:26 - Manuela Buxo: Executive Vice President, Specialty Care. Status: unknown. claim_id=alpha:claim:company:6f05ca0c-a52c-469e-bd04-7efad28236e7:leadership_role:27 - Natalie Bickford: Executive VP & Chief People Officer [CHRO]. Status: unknown. claim_id=alpha:claim:company:6f05ca0c-a52c-469e-bd04-7efad28236e7:leadership_role:28 - Olivier Charmeil: Executive Vice President of General Medicines. Status: unknown. claim_id=alpha:claim:company:6f05ca0c-a52c-469e-bd04-7efad28236e7:leadership_role:29 - Paul Hudson: CEO & Director [CEO]. Status: unknown. claim_id=alpha:claim:company:6f05ca0c-a52c-469e-bd04-7efad28236e7:leadership_role:30 - Paulo Fontoura: Executive Vice President, Head of Research & Development. Status: unknown. claim_id=alpha:claim:company:6f05ca0c-a52c-469e-bd04-7efad28236e7:leadership_role:31 - Pierre Chancel: Senior Vice President of Global Diabetes and Senior Vice President of Global Marketing. Status: unknown. claim_id=alpha:claim:company:6f05ca0c-a52c-469e-bd04-7efad28236e7:leadership_role:32 - Roy Papatheodorou: Executive VP & General Counsel [GC]. Status: unknown. claim_id=alpha:claim:company:6f05ca0c-a52c-469e-bd04-7efad28236e7:leadership_role:33 - Thomas Grenier: Executive Vice President, General Medicines. Status: unknown. claim_id=alpha:claim:company:6f05ca0c-a52c-469e-bd04-7efad28236e7:leadership_role:34 - Thomas Triomphe: Executive Vice President, Vaccines. Status: unknown. claim_id=alpha:claim:company:6f05ca0c-a52c-469e-bd04-7efad28236e7:leadership_role:35 - Véronique Jaillet: Executive Vice President, Chief People Officer, ad interim [CHRO]. Status: unknown. claim_id=alpha:claim:company:6f05ca0c-a52c-469e-bd04-7efad28236e7:leadership_role:36 ## Scoped resources - `alpha://company/sanofi` (contract): https://registry.alpha.ac/api/public/companies/sanofi?format=record - `alpha://company/sanofi/identity` (contract): https://registry.alpha.ac/api/public/companies/sanofi?format=record§ion=identity - `alpha://company/sanofi/corporate-structure` (contract): https://registry.alpha.ac/api/public/companies/sanofi?format=record§ion=corporate-structure - `alpha://company/sanofi/board` (contract): https://registry.alpha.ac/api/public/companies/sanofi?format=record§ion=board - `alpha://company/sanofi/committees` (contract): https://registry.alpha.ac/api/public/companies/sanofi?format=record§ion=committees - `alpha://company/sanofi/leadership` (contract): https://registry.alpha.ac/api/public/companies/sanofi?format=record§ion=leadership - `alpha://company/sanofi/ownership` (contract): https://registry.alpha.ac/api/public/companies/sanofi?format=record§ion=ownership - `alpha://company/sanofi/financials` (contract): https://registry.alpha.ac/api/public/companies/sanofi?format=record§ion=financials - `alpha://company/sanofi/capital-structure` (contract): https://registry.alpha.ac/api/public/companies/sanofi?format=record§ion=capital-structure - `alpha://company/sanofi/compensation` (contract): https://registry.alpha.ac/api/public/companies/sanofi?format=record§ion=compensation - `alpha://company/sanofi/governance` (contract): https://registry.alpha.ac/api/public/companies/sanofi?format=record§ion=governance - `alpha://company/sanofi/shareholder-governance` (contract): https://registry.alpha.ac/api/public/companies/sanofi?format=record§ion=shareholder-governance - `alpha://company/sanofi/audit` (contract): https://registry.alpha.ac/api/public/companies/sanofi?format=record§ion=audit - `alpha://company/sanofi/legal` (contract): https://registry.alpha.ac/api/public/companies/sanofi?format=record§ion=legal - `alpha://company/sanofi/risk` (contract): https://registry.alpha.ac/api/public/companies/sanofi?format=record§ion=risk - `alpha://company/sanofi/cyber` (contract): https://registry.alpha.ac/api/public/companies/sanofi?format=record§ion=cyber - `alpha://company/sanofi/ai-governance` (contract): https://registry.alpha.ac/api/public/companies/sanofi?format=record§ion=ai-governance - `alpha://company/sanofi/agents` (contract): https://registry.alpha.ac/api/public/companies/sanofi?format=record§ion=agents - `alpha://company/sanofi/ecosystem` (contract): https://registry.alpha.ac/api/public/companies/sanofi?format=record§ion=ecosystem - `alpha://company/sanofi/events` (contract): https://registry.alpha.ac/api/public/companies/sanofi?format=record§ion=events - `alpha://company/sanofi/relationships` (contract): https://registry.alpha.ac/api/public/companies/sanofi?format=record§ion=relationships - `alpha://company/sanofi/assessments` (contract): https://registry.alpha.ac/api/public/companies/sanofi?format=record§ion=assessments - `alpha://company/sanofi/evidence` (contract): https://registry.alpha.ac/api/public/companies/sanofi?format=record§ion=evidence ## Role modules - NOT_ASSERTED ## Attention - NO_RECORDS_FOUND ## Committee data - NO_RECORDS_FOUND ## Leadership - Frédéric Oudéa: Chairman of the Board of Directors. Claim: alpha:claim:company:6f05ca0c-a52c-469e-bd04-7efad28236e7:leadership_role:7. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:ab36e77cde3dfea6a93e3d80b940896af3abe1139dcb2518365cc8130b7f1594. - Anne-Françoise Nesmes: Independent director. Claim: alpha:claim:company:6f05ca0c-a52c-469e-bd04-7efad28236e7:leadership_role:8. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:ab36e77cde3dfea6a93e3d80b940896af3abe1139dcb2518365cc8130b7f1594. - Antoine Yver: Independent director. Claim: alpha:claim:company:6f05ca0c-a52c-469e-bd04-7efad28236e7:leadership_role:9. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:ab36e77cde3dfea6a93e3d80b940896af3abe1139dcb2518365cc8130b7f1594. - Barbara Lavernos: Director. Claim: alpha:claim:company:6f05ca0c-a52c-469e-bd04-7efad28236e7:leadership_role:10. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:ab36e77cde3dfea6a93e3d80b940896af3abe1139dcb2518365cc8130b7f1594. - Belén Garijo: Director. Claim: alpha:claim:company:6f05ca0c-a52c-469e-bd04-7efad28236e7:leadership_role:11. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:ab36e77cde3dfea6a93e3d80b940896af3abe1139dcb2518365cc8130b7f1594. - Carole Ferrand: Independent director. Claim: alpha:claim:company:6f05ca0c-a52c-469e-bd04-7efad28236e7:leadership_role:12. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:ab36e77cde3dfea6a93e3d80b940896af3abe1139dcb2518365cc8130b7f1594. - Christel Heydemann: Independent director. Claim: alpha:claim:company:6f05ca0c-a52c-469e-bd04-7efad28236e7:leadership_role:13. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:ab36e77cde3dfea6a93e3d80b940896af3abe1139dcb2518365cc8130b7f1594. - Christophe Babule: Director. Claim: alpha:claim:company:6f05ca0c-a52c-469e-bd04-7efad28236e7:leadership_role:14. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:ab36e77cde3dfea6a93e3d80b940896af3abe1139dcb2518365cc8130b7f1594. - Clotilde Delbos: Independent director. Claim: alpha:claim:company:6f05ca0c-a52c-469e-bd04-7efad28236e7:leadership_role:15. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:ab36e77cde3dfea6a93e3d80b940896af3abe1139dcb2518365cc8130b7f1594. - Emile Voest: Independent director. Claim: alpha:claim:company:6f05ca0c-a52c-469e-bd04-7efad28236e7:leadership_role:16. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:ab36e77cde3dfea6a93e3d80b940896af3abe1139dcb2518365cc8130b7f1594. - Humberto De Sousa: Director representing employees. Claim: alpha:claim:company:6f05ca0c-a52c-469e-bd04-7efad28236e7:leadership_role:17. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:ab36e77cde3dfea6a93e3d80b940896af3abe1139dcb2518365cc8130b7f1594. - Jean-Paul Kress: Independent director. Claim: alpha:claim:company:6f05ca0c-a52c-469e-bd04-7efad28236e7:leadership_role:18. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:ab36e77cde3dfea6a93e3d80b940896af3abe1139dcb2518365cc8130b7f1594. - John Sundy: Independent director. Claim: alpha:claim:company:6f05ca0c-a52c-469e-bd04-7efad28236e7:leadership_role:19. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:ab36e77cde3dfea6a93e3d80b940896af3abe1139dcb2518365cc8130b7f1594. - Lise Kingo: Independent director. Claim: alpha:claim:company:6f05ca0c-a52c-469e-bd04-7efad28236e7:leadership_role:20. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:ab36e77cde3dfea6a93e3d80b940896af3abe1139dcb2518365cc8130b7f1594. - Rachel Duan: Independent director. Claim: alpha:claim:company:6f05ca0c-a52c-469e-bd04-7efad28236e7:leadership_role:21. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:ab36e77cde3dfea6a93e3d80b940896af3abe1139dcb2518365cc8130b7f1594. - Wolfgang Laux: Director representing employees. Claim: alpha:claim:company:6f05ca0c-a52c-469e-bd04-7efad28236e7:leadership_role:22. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:ab36e77cde3dfea6a93e3d80b940896af3abe1139dcb2518365cc8130b7f1594. - Belén Garijo: Chief Executive Officer. Claim: alpha:claim:company:6f05ca0c-a52c-469e-bd04-7efad28236e7:leadership_role:23. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:7e12df99175fb3ccd34c20854cd6f4688ed4021ab16a4f4b0d18244f242be71d. - Brendan O'Callaghan: Executive Vice President, Manufacturing & Supply. Claim: alpha:claim:company:6f05ca0c-a52c-469e-bd04-7efad28236e7:leadership_role:24. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:7e12df99175fb3ccd34c20854cd6f4688ed4021ab16a4f4b0d18244f242be71d. - François Roger: Executive Vice President, Finance. Claim: alpha:claim:company:6f05ca0c-a52c-469e-bd04-7efad28236e7:leadership_role:25. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:7e12df99175fb3ccd34c20854cd6f4688ed4021ab16a4f4b0d18244f242be71d. - Jamie Haney: Executive Vice President, General Counsel. Claim: alpha:claim:company:6f05ca0c-a52c-469e-bd04-7efad28236e7:leadership_role:26. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:7e12df99175fb3ccd34c20854cd6f4688ed4021ab16a4f4b0d18244f242be71d. - Manuela Buxo: Executive Vice President, Specialty Care. Claim: alpha:claim:company:6f05ca0c-a52c-469e-bd04-7efad28236e7:leadership_role:27. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:7e12df99175fb3ccd34c20854cd6f4688ed4021ab16a4f4b0d18244f242be71d. - Natalie Bickford: Executive VP & Chief People Officer. Claim: alpha:claim:company:6f05ca0c-a52c-469e-bd04-7efad28236e7:leadership_role:28. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:92957232cda7b4f4969ba0c15b14af3477089724573936dae2eac2c5526b60a2. - Olivier Charmeil: Executive Vice President of General Medicines. Claim: alpha:claim:company:6f05ca0c-a52c-469e-bd04-7efad28236e7:leadership_role:29. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:f23ba52c61a177bb302a89b15faf35af6d08eb0ea29507cf3937f71db2626784. - Paul Hudson: CEO & Director. Claim: alpha:claim:company:6f05ca0c-a52c-469e-bd04-7efad28236e7:leadership_role:30. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:98ba8fe36197f99ead0894e59e5e341dd806557dd2143b813640312ba6eae3a0. - Paulo Fontoura: Executive Vice President, Head of Research & Development. Claim: alpha:claim:company:6f05ca0c-a52c-469e-bd04-7efad28236e7:leadership_role:31. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:7e12df99175fb3ccd34c20854cd6f4688ed4021ab16a4f4b0d18244f242be71d. - Pierre Chancel: Senior Vice President of Global Diabetes and Senior Vice President of Global Marketing. Claim: alpha:claim:company:6f05ca0c-a52c-469e-bd04-7efad28236e7:leadership_role:32. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:362187a2aa529af3478db160007a10cc491500190df4567664c02c1cb669a13d. - Roy Papatheodorou: Executive VP & General Counsel. Claim: alpha:claim:company:6f05ca0c-a52c-469e-bd04-7efad28236e7:leadership_role:33. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:71f3203dcc57cbb10718c30342ddff61222cbc421f7c6fe091e7d2b8768ec146. - Thomas Grenier: Executive Vice President, General Medicines. Claim: alpha:claim:company:6f05ca0c-a52c-469e-bd04-7efad28236e7:leadership_role:34. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:7e12df99175fb3ccd34c20854cd6f4688ed4021ab16a4f4b0d18244f242be71d. - Thomas Triomphe: Executive Vice President, Vaccines. Claim: alpha:claim:company:6f05ca0c-a52c-469e-bd04-7efad28236e7:leadership_role:35. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:7e12df99175fb3ccd34c20854cd6f4688ed4021ab16a4f4b0d18244f242be71d. - Véronique Jaillet: Executive Vice President, Chief People Officer, ad interim. Claim: alpha:claim:company:6f05ca0c-a52c-469e-bd04-7efad28236e7:leadership_role:36. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:7e12df99175fb3ccd34c20854cd6f4688ed4021ab16a4f4b0d18244f242be71d. ## Roles - PUBLISHED ## Governance - NOT_ASSERTED ## Board committees - PUBLISHED ## Financials - NOT_ASSERTED ## Workforce - NOT_ASSERTED ## Market and index context - CAC 40 (PX1). Claim: alpha:claim:company:6f05ca0c-a52c-469e-bd04-7efad28236e7:index_membership:37. Valid from: 2026-06-30. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:157a1818640a0275177cb20ee0d8921456c96842a440b9171a1933a32ab05c50. ## Legal Name - Sanofi. Claim: alpha:claim:company:6f05ca0c-a52c-469e-bd04-7efad28236e7:legal_name:1. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:bd1d2eb7afaabee761c6be63885d4e6e835018c319ac3cedecaddff69031440f. ## Entity Status - Public listing published. Claim: alpha:claim:company:6f05ca0c-a52c-469e-bd04-7efad28236e7:entity_status:3. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:bd1d2eb7afaabee761c6be63885d4e6e835018c319ac3cedecaddff69031440f. ## Published Fact - US. Claim: alpha:claim:company:6f05ca0c-a52c-469e-bd04-7efad28236e7:published_fact:5. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:bd1d2eb7afaabee761c6be63885d4e6e835018c319ac3cedecaddff69031440f. - Healthcare. Claim: alpha:claim:company:6f05ca0c-a52c-469e-bd04-7efad28236e7:published_fact:6. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:bd1d2eb7afaabee761c6be63885d4e6e835018c319ac3cedecaddff69031440f. ## Security Listing - SNY (NASDAQ). Claim: alpha:claim:company:6f05ca0c-a52c-469e-bd04-7efad28236e7:security_listing:38. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:bd1d2eb7afaabee761c6be63885d4e6e835018c319ac3cedecaddff69031440f. - SNYNF (OTC). Claim: alpha:claim:company:6f05ca0c-a52c-469e-bd04-7efad28236e7:security_listing:39. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:bd1d2eb7afaabee761c6be63885d4e6e835018c319ac3cedecaddff69031440f. - SAN (EURONEXT PARIS). Claim: alpha:claim:company:6f05ca0c-a52c-469e-bd04-7efad28236e7:security_listing:40. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:bd1d2eb7afaabee761c6be63885d4e6e835018c319ac3cedecaddff69031440f. ## Coverage states | Field | Value | | --- | --- | | Identity | PUBLISHED | | Business | PUBLISHED | | Leadership | PUBLISHED | | Board and committees | PUBLISHED | | Governance | NOT_ASSERTED | | Financials | NOT_ASSERTED | | Workforce | NOT_ASSERTED | | Ownership | NOT_ASSERTED | | Ratings | NOT_PUBLISHED | | Market and index context | PUBLISHED | ## Public sources - alpha:projection-evidence:bd1d2eb7afaabee761c6be63885d4e6e835018c319ac3cedecaddff69031440f: [Alpha canonical company public projection](https://www.alpha.ac/api/public/companies/sanofi). - alpha:projection-evidence:document:ab36e77cde3dfea6a93e3d80b940896af3abe1139dcb2518365cc8130b7f1594: [Sanofi Board of Directors](https://www.sanofi.com/en/our-company/governance/board-of-directors). - alpha:projection-evidence:document:7e12df99175fb3ccd34c20854cd6f4688ed4021ab16a4f4b0d18244f242be71d: [Sanofi Executive Committee press release 21 July 2026](https://www.sanofi.com/assets/dotcom/pressreleases/2026/2026-07-21-16-00-00-3330752en.pdf). - alpha:projection-evidence:document:92957232cda7b4f4969ba0c15b14af3477089724573936dae2eac2c5526b60a2: [Sanofi SA key executives](https://financialmodelingprep.com/stable/key-executives?symbol=SNY). - alpha:projection-evidence:document:f23ba52c61a177bb302a89b15faf35af6d08eb0ea29507cf3937f71db2626784: [Sanofi SA key executives](https://financialmodelingprep.com/stable/key-executives?symbol=SNY). - alpha:projection-evidence:document:98ba8fe36197f99ead0894e59e5e341dd806557dd2143b813640312ba6eae3a0: [Sanofi SA key executives](https://financialmodelingprep.com/stable/key-executives?symbol=SNY). - alpha:projection-evidence:document:362187a2aa529af3478db160007a10cc491500190df4567664c02c1cb669a13d: [Sanofi SA key executives](https://financialmodelingprep.com/stable/key-executives?symbol=SNY). - alpha:projection-evidence:document:71f3203dcc57cbb10718c30342ddff61222cbc421f7c6fe091e7d2b8768ec146: [Sanofi SA key executives](https://financialmodelingprep.com/stable/key-executives?symbol=SNY). - alpha:projection-evidence:157a1818640a0275177cb20ee0d8921456c96842a440b9171a1933a32ab05c50: [CAC 40](https://live.euronext.com/sites/default/files/documentation/index-composition/CAC_40_Index_Composition.pdf). ## Rights | Field | Value | | --- | --- | | public_retrieval | allowed | | agent_retrieval | allowed | | redistribution | not_granted | | model_training | not_granted | | commercial_use | not_specified | | relationship_pathfinding | not_granted | | direct_contact | not_granted | ## Limitations - Absence of a leadership role, committee, or disclosure is not evidence that it does not exist. - Only explicitly published canonical company identity and current confirmed public roles are included. - Absence of a board, committee, executive, listing, or claim is not evidence that it does not exist. - Public retrieval does not grant redistribution, model-training, direct-contact, or relationship-pathfinding rights. - This Company Profile is an identity and evidence record, not an Alpha rating. ## Alternate representations - [Canonical profile](https://registry.alpha.ac/companies/sanofi) - [Public Markdown](https://registry.alpha.ac/companies/sanofi.md) - [Public JSON](https://registry.alpha.ac/api/public/companies/sanofi?format=record) - [JSON-LD](https://registry.alpha.ac/api/public/companies/sanofi?format=jsonld) - MCP resource: `alpha://companies/sanofi` at https://mcp.alpha.ac/mcp ## Connected governance records Structured intelligence is not currently available. Existing published profile evidence remains accessible. ## Critical-risk oversight Snapshot as of 2026-10-23T09:34:37.525798+00:00; recorded 2026-10-23T09:34:37.525798+00:00. Every published assignment for this snapshot is listed. Only explicitly reviewed, rights-cleared assignments in effect on the as-of date, in the company's own wording. An assignment shows where oversight is placed, not whether it is effective. Missing records do not establish absence.